California Partnership for Access to Treatment

CPAT is a diverse network of advocacy and community groups, health care providers and employers, committed to ensuring a healthy and productive California.

[California Partnership for Access to Treatment @CaAccess]

A Tennessee couple, one Republican and one Democrat, share one gripe: PBMs. He found his blood pressure med cost less in cash than through his CVS Caremark plan. @KFFHealthNews and @NPR report Tennessee and Arkansas are reining them in.
Read more here: https://t.co/0jyIs69lOV

[California Partnership for Access to Treatment @CaAccess]

John Oliver spent his @LastWeekTonight return on @UnitedHealthGrp Cole Schmidtknecht, 22, died after his inhaler jumped from $60 to $539 through OptumRx. The bipartisan Break Up Big Medicine Act would break up companies like this.
Watch the segment here: https://t.co/CTUyPuNH4t

[California Partnership for Access to Treatment @CaAccess]

The @US_FDA lets drugs to market faster, then requires safety studies after approval. @KFFHealthNews found nearly 600 of those studies running late. @Amgen's Tavneos, linked to dozens of liver injury cases, still hasn't finished its study.
Read more here: https://t.co/yQ1DPmcS4f

[California Partnership for Access to Treatment @CaAccess]

Nearly 25,000 Californians could be moved from a biologic to a cheaper biosimilar next year under SB 1094, signed by @CAgovernor unless their doctor objects. Backers cite savings; rheumatologists and patient groups fear disrupted care.
Read more here:
https://t.co/uwt8yJ4EFP

[California Partnership for Access to Treatment @CaAccess]

California men die 5+ years before women, and half of male deaths come before 75. @Movember's new report calls for a state plan to reach men where they are. Saturday is #WorldMentalHealthDay, and mental health is men's health too.
Read more here: https://t.co/9Uc1OF5ZUc

[California Partnership for Access to Treatment @CaAccess]

We’re thrilled to see the @FDA advisory committee recognize the potential of Galleri and the importance of continued innovation in cancer detection #MCED. https://t.co/PXylCCujC8

[California Partnership for Access to Treatment @CaAccess]

A study of 92 million medical records found 1.1 million Americans taking GLP-1s like Ozempic with no obesity or diabetes diagnosis. Off-label use is up 15x since 2021, and experts warn there's little safety data for these patients.
Read more here: https://t.co/piYWWmkqK3

[California Partnership for Access to Treatment @CaAccess]

Great news for California patients! #AB2009, by @PhillipChenCA and @AsmSolache, was signed by @CAgovernor. The bill will modernize source plasma donation regulations and support a more reliable supply of plasma-derived medicines for those who depend on them.

[California Partnership for Access to Treatment @CaAccess]

Dr. Wayne Ho sees how GLP-1s improve his patients’ lives, but the reversal of Medi-Cal coverage adds to the hurdles faced by vulnerable patients who now risk losing the progress they have “fought incredibly hard to achieve.”
Read more @calhealthreport >> https://t.co/Ep8ZvjZXYZ

[California Partnership for Access to Treatment @CaAccess]

Going to be a great & informative webinar hosted by @Looms4Lupus! Don't forget to register today to hear from experts on the #340Bprogram and how proposed changes may affect patients.

When: TOMORROW, September 24 at 9:00am PST
Register here: https://t.co/jwhXdMD0A0

[Looms4Lupus @Looms4Lupus]

Join @Looms4Lupus for a webinar on proposed changes to the 340B Program and what they could mean for patients, caregivers, and access to care.

📅 Thursday, September 24, 2026
🕘 9:00 AM PT | 12:00 PM ET
💻 Zoom Webinar
🔗 Register today: https://t.co/O0lH23J7mz

#Lupus #PatientEducation #HealthcarePolicy #340B #PatientAdvocacy #HealthEquity #Looms4Lupus

[California Partnership for Access to Treatment @CaAccess]

@afshineemrani @RealClearHealth We’ve made tremendous progress in identifying heart disease before a heart attack happens. @afshineemrani makes the case for bringing that same urgency and focus on earlier detection to cancer. #MCED

[California Partnership for Access to Treatment @CaAccess]

Policymakers reversed #GLP1 coverage due to budget concerns. But there is a greater cost: undoing health equity for the millions of #LGBTQ+ Californians who rely on Medi-Cal to treat and manage #obesity.
From Dr. Sera Ramadan, DO via @GlendaleNews_P >> https://t.co/IrHbc03se2

[California Partnership for Access to Treatment @CaAccess]

Behind #AB2009 are real patients, families, and caregivers who rely on plasma-derived medicines every day. We urge @CAgovernor to sign this bill into law and ensure California’s policies keep pace with patient need.

[California Partnership for Access to Treatment @CaAccess]

The menopause journey isn't one-size-fits-all. Join @PFCD and State Senator Dr. Akilah Weber Pierson for a free luncheon seminar focused on the unique experiences of Black women. Register today: https://t.co/7HTp6moRqL

[California Partnership for Access to Treatment @CaAccess]

Tomorrow: Join @LupusColorado for an educational webinar on the #340B program, recent federal actions, and how decisions are impacting state-level issues. Featuring expert insights from @TIICANN and @blkwomenshealth
Register here: https://t.co/rdDVQEA3CZ

[California Partnership for Access to Treatment @CaAccess]

California is one step closer to improving access to life-saving plasma-derived medicines!

We now call on the California Assembly & @CAgovernor to support #AB2009, legislation that will modernize outdated source plasma regulations.

https://t.co/RvT20KXL87

[Liver Coalition @LiverCoalition]

https://t.co/mIkQ4Prd4v

[California Partnership for Access to Treatment @CaAccess]

Government price-setting policies based on #QALYs risk reducing patients to formulas rather than recognizing individual needs. People living with rare diseases, disabilities, and chronic conditions deserve equitable access to treatment.
Read more: https://t.co/9GVTiSjjtU

[California Partnership for Access to Treatment @CaAccess]

A new FDA-approved gene therapy is giving hope to patients with sickle cell disease. Patients are experiencing fewer pain episodes after treatment, marking an encouraging advancement in #sicklecell care.
Read more here: https://t.co/4VwJHRyzkh

[California Partnership for Access to Treatment @CaAccess]

A federal investigation found that some of the largest Medicare Advantage insurers denied medically recommended rehabilitative care at higher rates than their peers, often approving coverage only after patients appealed.
Read more here: https://t.co/7AIhHRsvGq